Abstract
Relationship between compliance and clinical recurrence in patients with quiescent ulcerative colitis receiving MMX® mesalamine 2.4g/day maintenance therapy
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
